JP6807922B2 - 止血、組織障壁、創傷治癒、および美容術のための生体適合性カルボキシメチルセルロースマトリックス（ｂｃｍ） - Google Patents

止血、組織障壁、創傷治癒、および美容術のための生体適合性カルボキシメチルセルロースマトリックス（ｂｃｍ） Download PDF

Info

Publication number
JP6807922B2
JP6807922B2 JP2018517351A JP2018517351A JP6807922B2 JP 6807922 B2 JP6807922 B2 JP 6807922B2 JP 2018517351 A JP2018517351 A JP 2018517351A JP 2018517351 A JP2018517351 A JP 2018517351A JP 6807922 B2 JP6807922 B2 JP 6807922B2
Authority
JP
Japan
Prior art keywords
bcm
medical device
biocompatible
wound
carboxymethyl cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018517351A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018536630A5 (enExample
JP2018536630A (ja
Inventor
グイティング リン，
グイティング リン，
ヴィッキー フェン，
ヴィッキー フェン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeScience PLUS Inc
Original Assignee
LifeScience PLUS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LifeScience PLUS Inc filed Critical LifeScience PLUS Inc
Publication of JP2018536630A publication Critical patent/JP2018536630A/ja
Publication of JP2018536630A5 publication Critical patent/JP2018536630A5/ja
Application granted granted Critical
Publication of JP6807922B2 publication Critical patent/JP6807922B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C08L1/286—Alkyl ethers substituted with acid radicals, e.g. carboxymethyl cellulose [CMC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
JP2018517351A 2015-10-07 2016-06-06 止血、組織障壁、創傷治癒、および美容術のための生体適合性カルボキシメチルセルロースマトリックス（ｂｃｍ） Active JP6807922B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562238676P 2015-10-07 2015-10-07
US62/238,676 2015-10-07
PCT/US2016/036100 WO2017062072A1 (en) 2015-10-07 2016-06-06 Biocompatible carboxymethylcellulose matrix (bcm) for hemostasis, tissue barrier wound healing, and cosmetology

Publications (3)

Publication Number Publication Date
JP2018536630A JP2018536630A (ja) 2018-12-13
JP2018536630A5 JP2018536630A5 (enExample) 2019-06-27
JP6807922B2 true JP6807922B2 (ja) 2021-01-06

Family

ID=58488241

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018517351A Active JP6807922B2 (ja) 2015-10-07 2016-06-06 止血、組織障壁、創傷治癒、および美容術のための生体適合性カルボキシメチルセルロースマトリックス（ｂｃｍ）

Country Status (5)

Country Link
US (2) US20180280561A1 (enExample)
EP (1) EP3359206A4 (enExample)
JP (1) JP6807922B2 (enExample)
CN (1) CN108367093A (enExample)
WO (1) WO2017062072A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107604739B (zh) * 2017-09-26 2019-06-07 江南大学 一种过滤用棉秆皮纤维与壳聚糖复合非织布的制备方法
CN111840633B (zh) * 2019-04-29 2022-08-23 上海硅健生物材料有限公司 一种皮肤修复膜及其制备方法
EP4164704A4 (en) * 2020-06-10 2024-07-10 The Australian National University Haemostatic material
CN115046907B (zh) * 2022-08-15 2022-10-28 启东市鸿盛纺织有限公司 一种可吸收止血纱布的质量评估方法及系统
AU2023333216A1 (en) * 2022-08-30 2025-03-13 Lifescienceplus, Inc. Wound healing and related products and methods thereof for regulating tissue growth factors for healing

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1405145A (en) * 1919-11-10 1922-01-31 Morse Chain Co Method of correcting the pitch in drive chains
DE2358150C2 (de) * 1973-11-22 1982-03-18 Hoechst Ag, 6000 Frankfurt Verfahren zum Herstellen von Wasser aufnehmenden, aber darin zu mehr als 50% unlöslichen Celluloseethern
SU1405145A3 (ru) * 1983-06-20 1999-10-20 Московская медицинская академия им.И.М.Сеченова Способ получения средства для лечения гнойных ран
JP3114016B2 (ja) * 1998-05-15 2000-12-04 株式会社ホギメディカル 細胞接着促進効果を有する創傷止血材
JP3578627B2 (ja) * 1998-05-15 2004-10-20 株式会社ホギメディカル 創傷患部の治癒を促進する組織シーラント
WO2002087643A1 (en) * 2001-04-30 2002-11-07 Beijing Textile Research Institute Water soluble cellulose etherified derivates styptic materials
JP2002369874A (ja) * 2001-06-14 2002-12-24 Terumo Corp 止血材料
RU2249467C2 (ru) * 2002-11-25 2005-04-10 ООО Научно-производственное предприятие "ЭРЛОН", Лтд. Медицинский материал и изделия на его основе
RU2353626C1 (ru) * 2007-10-25 2009-04-27 Институт химии растворов РАН Способ получения волокнистой целлюлозы из целлюлозосодержащего волокна
CA2716872C (en) * 2008-02-29 2015-02-10 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
CN103120802B (zh) * 2012-07-26 2015-02-25 佛山市优特医疗科技有限公司 可溶性止血纱布及其制备方法
CN102908650B (zh) * 2012-09-25 2015-06-17 北京维索科科技有限公司 可溶性止血材料生产工艺
CN103041437A (zh) * 2012-12-25 2013-04-17 武汉纺织大学 一种高强度、高吸水性含羧甲基纤维素医用敷料及其制备方法
CN105209082A (zh) * 2013-05-09 2015-12-30 旭化成纤维株式会社 使用了羧甲基纤维素的医疗用材料
CN104389155B (zh) * 2014-12-18 2016-02-24 山东蓝汀制药有限公司 一种医用材料及制备方法

Also Published As

Publication number Publication date
EP3359206A4 (en) 2019-05-15
US20180280561A1 (en) 2018-10-04
WO2017062072A1 (en) 2017-04-13
EP3359206A1 (en) 2018-08-15
CN108367093A (zh) 2018-08-03
JP2018536630A (ja) 2018-12-13
US20220072192A1 (en) 2022-03-10

Similar Documents

Publication Publication Date Title
US10314937B2 (en) Biocompatible hemostatic product and preparation method thereof
JP7013336B2 (ja) インサイチュー架橋性ポリマー組成物およびその方法
US20220072192A1 (en) Biocompatible carboxymethylcellulose matrix (bcm) for hemostasis, tissue barrier, wound healing, and cosmetology
JP7099822B2 (ja) コラーゲンで強化した組織移植片
EP2233157A1 (en) A biocompatible denatured starch sponge material
WO2017011982A1 (zh) 贻贝粘蛋白产品及其抑制皮肤炎症的应用
JPH07500095A (ja) 局所止血用止血組成物
US9962402B2 (en) Healing composition for topical application
WO2016192571A1 (zh) 作为再生性皮肤替代物的多功能皮肤或创面复合敷料
CN101184513A (zh) 用于控制生物流体的药剂及其应用方法
Bielecki et al. Wound dressings and cosmetic materials from bacterial nanocellulose
JP7378486B2 (ja) 医療用接着剤及びその調製方法、その用途
CN109453411B (zh) 一种壳聚糖敷料
JP2014520837A (ja) 病理学的瘢痕の予防および治療のためのオリゴサッカライド化合物の使用
Khorasani et al. The effects of Aloe Vera cream on split-thickness skin graft donor site management: a randomized, blinded, placebo-controlled study
JP5796728B1 (ja) 創傷治癒を促進し生体諸臓器の被覆（コーチング）及び庇護を目的とした生体皮膜剤。
JP2025019175A (ja) コラーゲンハイドロゲル被膜形成剤
CN102988407A (zh) 淀粉-透明质酸止血剂及其制备方法
CN107715167A (zh) 作为骨蜡替代物的壳聚糖基止血糊剂及制备方法
CN106963977A (zh) 一种抑制瘢痕形成的灯盏花素/壳聚糖复合水凝胶及其制备方法
JPH04500799A (ja) グルタルアルデヒドにより架橋したビニルアセテートとビニルアルコールのコポリマー、その製造方法及びそれをベースとする医薬品
CN114269350B (zh) 局部止血组合物
RU2743425C1 (ru) Гемостатическое средство на основе хитозанового аэрогеля
CN109529097A (zh) 一种可溶性止血纱布
Li et al. Advances in absorbable hemostatic materials for nasal bleeding and post-sinus surgery

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190521

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190521

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200512

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200709

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201014

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20201124

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20201208

R150 Certificate of patent or registration of utility model

Ref document number: 6807922

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250